Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

CAS No :

1315629-79-8 (KLS-A06002)

Molecular Formula:

C33H35FN2O7

Molecular Weight:

556.6

Chemical Name:

(3R)-4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2′,3′:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid

Add to Enquiry Basket
Product Enquiry

Related Products

Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Ethyl Ester

CAS No: ​1624328-52-4

Molecular Formula:​ C35H37FN2O4

Molecular Weight: ​568.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity P

CAS No: ​581772-29-4

Molecular Formula:​ C36H39FN2O5

Molecular Weight: ​598.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Lactone 3-O-Methyl Ether

CAS No: ​NA

Molecular Formula:​ C34H35FN2O4

Molecular Weight: ​ 554.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Acid Isopropyl Ester

CAS No: ​ 1035205-25-4

Molecular Formula:​ C36H41FN2O5

Molecular Weight: ​600.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity F

CAS No: ​887196-24-9 (acid) ; 1105067-87-5

Molecular Formula:​ C40H47FN3NaO8

Molecular Weight: ​739.8

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity D

CAS No: ​148146-51-4

Molecular Formula:​ C26H22FNO4

Molecular Weight: ​431.46

Inv. Status:​


Add to Enquiry Basket

Atorvastatin 2,3,4,5-Dianhydro Acid

CAS No: ​2588261-49-6

Molecular Formula:​ C33H31FN2O3

Molecular Weight: ​522.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin 5-Oxo Acid

CAS No: ​1391052-82-6

Molecular Formula:​ C33H33FN2O5

Molecular Weight: ​556.62

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog

CAS No: ​1316291-19-6

Molecular Formula:​ C33H34FN2NaO7

Molecular Weight: ​612.62

Inv. Status:​


Add to Enquiry Basket

API – Impurities | Specialty Chemicals

Dribbble Pinterest

About

Kemiezen Lifesciences is established with a zeal of support the world with the best chemistry solutions with a group of dedicated scientists having 15 years of experience in the pharmaceutical industry.

Contact Us